As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...

Jefferies said it still regards GSK’s fundamental value as “compelling,” adding that its 2027+ estimates for sales and ...

The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.

Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...